Heron Therapeutics, Inc. (HRTX) was a big mover last session with its shares rising over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has gained over 22% since June 9.
This specialty pharmaceutical company has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate hasn’t been in trend either. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Heron Therapeutics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is positive.
Investors interested in the Med-Drugs industry may consider better-ranked stocks like Aeolus Pharmaceuticals Inc. (AOLS), Ariad Pharmaceuticals Inc. (ARIA) and Aerie Pharmaceuticals, Inc. (AERI). All the three stocks hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
HERON THERAPEUTICS INC (HRTX): Free Stock Analysis Report
AEOLUS PHARMACEUTICL (AOLS): Free Stock Analysis Report
AERIE PHARMACEUTICALS INC (AERI): Free Stock Analysis Report
ARIAD PHARMACEUTICALS INC (ARIA): Free Stock Analysis Report
Zacks Investment Research